Use of CD25 binding molecules in steroid-resistant patients

Details for Australian Patent Application No. 2002315271 (hide)

Owner University of Bristol

Inventors Dayan, Colin Mark; Hearing, Stephen David; Norman, Michael Roden

Agent Davies Collison Cave

Pub. Number AU-B-2002315271

PCT Number PCT/EP02/03808

PCT Pub. Number WO2002/081508

Priority 0108817.8 06.04.01 GB; 0108821.0 06.04.01 GB; 0108816.0 06.04.01 GB

Filing date 5 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 3 August 2006

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 0108817.8 06.04.01 GB; 0108821.0 06.04.01 GB; 0108816.0 06.04.01 GB

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002315271

3 August 2006 Application Accepted

  Published as AU-B-2002315271

7 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002315272-METHOD FOR THE ABSORPTIVE OUTWARD TRANSFER OF AMMONIA AND METHANE OUT OF SYNTHESIS GAS

2002315270-FIXING DEVICE FOR MOULDS